Bellevue Group Ag Adma Biologics, Inc. Transaction History
Bellevue Group Ag
- $5.02 Billion
- Q4 2024
A detailed history of Bellevue Group Ag transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 16,900 shares of ADMA stock, worth $280,709. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,900
Previous 25,900
34.75%
Holding current value
$280,709
Previous $517,000
44.1%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$310 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$302 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$247 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$188 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$91.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.26B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...